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  Diet and Nutrition in TS  
 
Understanding the impact of diet and nutrition on symptoms of Tourette 
Syndrome: A Scoping Review 
 
 
 
ABSTRACT 
 
Anecdotal reports frequently suggest some dietary involvement in the maintenance of 
tics in children with Tourette Syndrome (TS). This scoping review aimed to 1) 
understand the possible influence of diet as a trigger of tics 2) map out the existing 
studies documenting dietary interventions in children with TS. Current evidence 
suggests no single diet to benefit individuals with TS. However, reports from parents 
of children with TS suggest that certain allergens in food may exacerbate tic related 
symptoms. For example, an increase in tics has been related to the consumption of 
caffeine and refined sugar. Moreover, oligoantigenic diets and sugar-free diets have 
been identified as significantly reducing tics. More research is urgently needed to 
develop more accurate guidance for parents and children with TS, as many have 
reported using dietary and nutritional supplements, despite the lack of evidence 
detailing any benefits, side effects and recommended doses. 
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INTRODUCTION 
 
Tourette Syndrome (now known as Tourette Disorder in the Diagnostic Statistical 
Manual 5; APA, 2013) is a life-long neurodevelopmental disorder, characterized by 
repeated twitches, movements or sounds, otherwise known as tics. Tics can be 
sudden, rapid and include both non-rhythmic motor movement and vocalisation. 
While the frequency of tics may differ, typical age of onset is between the ages of 7-
12 years, and need to be present for at least a year in order to gain an official 
diagnosis of Tourette Syndrome (TS). However, when symptoms involve persistent 
motor or vocal tics, a diagnosis of Persistent (chronic) motor or tic disorder 
(symptoms more than a year), or a diagnosis of provisional tic disorder (symptoms 
present for less than a year), is given (APA, 2013). Tic disorders are considered to be 
more common than TS, and have a prevalence rate of between 1% and 29% 
(depending on the methods adopted, the diagnostic criteria employed, and whether or 
not the sample was a non clinical or clinical sample; Robertson, 2008). For example, 
high prevalence rates are often reported when the inclusion criteria involves children 
who show intermittent and unpredictable motor or vocal tics, and which appear out of 
context of normal motor activity (e.g. Lanzi et al., 2004). However, these children 
may not reach the threshold for a diagnosis of a tic disorder. In contrast, when using 
community samples of children between the ages of 5 and 18 years, prevalence 
figures for TS consistently range between 0.4-3.8% (Robertson, Eapen and Cavanna, 
2009). 
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Tics are often classified into simple and complex categories. Simple motor tics can be 
behaviours such as eye blinks, shrugs and grimaces; more complex tics can include 
the touching of objects and/or people. Furthermore, simple vocal tics can include 
coughs and grunts, whereas more complex vocal tics might involve repetition of their 
own (palilalia), or someone else’s (echolalia), speech (Chilvers et al., 2010). In 
addition to motor and vocal classification of tics, there is some unpredictability 
surrounding the symptoms. For example, the body parts affected by tics, and the 
frequency and severity of the tics, can change over time (Singer, 2005).  
 
The severity and frequency of tics has also been shown to be influenced by an 
assortment of environmental factors, particularly those leading to increased levels of 
anxiety, stress, excitement and fatigue (e.g. Findley et al., 2003). Importantly, 
anecdotal reports and some studies seeking to determine the relationship between 
environmental factors and tic symptomology have hinted at the role diet and nutrition 
could play in tic related behaviours (Silva, Munoz, Barickman and Friedhoff, 1995). 
Yet, while dietary and nutritional factors have been found to affect a range of 
neurological conditions, there appears to be relatively little research addressing diet 
and nutrition in TS. 
 
There are several important reasons to address diet and nutrition in TS. Firstly, 
medication is one of the main forms of treatment, and although it is relatively 
successful in treating symptoms, it has been associated with a range of adverse effects 
including sedation, increased levels of depression and anxiety, as well as having a 
debilitating effect on motor function. First-generation antipsychotics (FGAs), also 
known as neuroleptics, conventional or typical antipsychotics, have the tendency to 
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cause movement disorders, extrapyramidal side effects and tardive dyskinesia. While 
more newly marketed atypical drugs, such as ripseridone, aripiprazole, clozapine are 
considered to be safer, they are still associated with a range of adverse side effects, 
including type II diabetes (Scahil et al., 2006). Importantly, weight gain has been 
associated with all types of antipsychotics, although it has been more frequently 
linked to the newer atypical drugs, and can lead to additional immediate and long-
term health risks including obesity, diabetes mellitus, and hyperlipidemia (Bak et al., 
2014).  
 
Degrauw, Li and Gilbert (2009) conducted one of the only studies addressing the 
affect of medication on both growth and weight in TS. The effects of neuroleptic 
drugs on body mass index (BMI) were assessed in neuroleptic-treated and non-
neuroleptic-treated children and adolescents with TS (groups were matched for age 
and gender). Results revealed that neuroleptic-treated children gained significantly 
more weight than untreated controls after 1 year (but not 2 or 3 years). More recently, 
Pringsheim, Ho, Sarna, Hammer and Pattern (2017) evaluated the risk of adverse 
effects of antipsychotics (Risperidone, and Aripiprazole) over a mean period of 10 
months and 3 days in 57 children with TS. They found a significant increase in both 
BMI and waist circumference percentiles. While the Canadian Alliance for 
Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) 
guidelines have now been issued to help professionals monitor weight gain and 
growth, it is unclear which professionals choose to follow these guidelines 
(Pringsheim et al., 2011). There also exists a clear need for more longitudinal studies, 
not only addressing fluctuation in weight following administration of medication, but 
also studies that control for dietary effects in TS. 
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Secondly, is well known that not only does a child’s early eating habits form the basis 
for their dietary habits as an adult, but can also lead to poor physical and mental 
health (Wachs, 2009). Importantly, both anecdotal and case reports suggest that many 
individuals with TS are more likely to consume an unhealthy diet, and show a 
predisposition to being overweight, compared to those without TS. For example, 
Liang, Sun, Ma, and Liu (2015) investigated the dietary behaviour, food variety and 
nutrient intake in 48 adult patients with TS over a 24 hour period. Results revealed 
over half of those surveyed reported consuming low levels of protein, calcium, zinc, 
retinal, thiamine, riboflavin and vitamin C. Participants also reported consuming more 
carbohydrates and fats than may be considered healthy. Therefore, specific nutritional 
guidelines appear to be needed for individuals with TS to follow. 
 
Finally, more alternative treatments are needed aside from the pharmaceutical and 
behavioural-based interventions (e.g. habit reversal) that are currently being offered 
(Himle, Woods, Piacentini and Walkup, 2006). Table 1 illustrates the current 
treatments that are on offer for TS, and some of the associated difficulties with these 
treatments. Furthermore, anecdotal reports and TS forums often describe benefits in 
the reduction of tics after the incorporation of nutritional and dietary changes (Mantel, 
Meyers, Tran, Rogers and Jacobson, 2004), yet little empirical research has been 
carried out to support these reports. This is in stark contrast to the vast number of 
studies addressing nutrition and diet in several disorders comorbid with TS, such as 
Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorders 
(ASD). For example, improvements in behavioural symptoms of ASD have been 
reported with the use of various supplements, including omega-3 fatty acids 
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(Amminger, 2007) and vitamin C (Dolske et al., 1993). In children with ADHD, 
symptoms have been shown to improve with flax oil and Vitamin C supplements 
(Joshi et al., 2006). 
 
Given the impact of motor and vocal tics on the lives of individuals with TS, the 
suggestion they are more vulnerable to unhealthy eating habits, and also the multiple 
adverse effects of the use of pharmaceutical interventions, it is important to increase 
our understanding of what role, if any, dietary factors and eating behaviours play in 
the frequency and severity of tics.  
Table 1 here 
 
Current review 
In contrast to a literature review, which aims to evaluate the existing literature related 
to a clearly defined research question (Davis, Drey and Gould, 2009), a scoping 
review adopts transparent and rigorous methodology to identify gaps in the literature 
and enhance future research (Arskey and O’Malley, 2005). Therefore, a scoping 
review can provide a first assessment of a body of emergent research. The purpose of 
the current scoping review was to a) understand the possible influence of different 
vitamins and food types on Tics; b) map out the existing studies documenting dietary 
interventions in individuals with TS. Here the term ‘dietary interventions’ referred to 
any alteration or treatment of an individual's diet with a planned goal, and included 
any supplement, vitamin, food and/or diet. 
 
METHODS 
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The search used the electronic databases of PubMed, Medline, PsychInfo and Web of 
Science to identify relevant research. Publication year was not restricted. 
Combinations of the following search terms were used: TS, Tourettes Disorder, Gilles 
de la Tourette Syndrome, food, diet, nutrient, nutrition, vitamins, fatty acids, 
magnesium, iron, sugar, amino acids and complementary alternative medicines. To 
provide the most comprehensive list of the literature, the references lists of papers 
obtained from the search terms were also manually scanned. This resulted in fifteen 
articles and one book chapter. Articles were further screened for relevance, and five 
articles were removed as they only referred briefly to disorders comorbid with ASD, 
OCD and/or ADHD and were not specific to TS. Therefore, the final selection 
included nine articles and one book chapter, most of which were based on either 
clinical observations or self-report surveys. Only two articles involved an empirical 
investigation of the impact of diet and nutrition in TS, and only four studies reported 
comorbid symptoms of the children and adults with TS. Furthermore, none of the 
studies used control groups, which highlights a lack of comparative data on children 
and adults of a similar age without TS. Therefore, due to the limited studies available, 
all were included in the review (see Table 2 for a summary of the selected studies).  
 
Table 2 here 
 
RESULTS 
 
1) The influence of specific diets and nutrition on tics 
 
Caffeine 
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Previous research has shown that CNS stimulants such as methylphenidate or cocaine 
precipitate or worsen tics (Cardoso and Jankovic, 1993), although more recent 
research has failed to establish a direct link between the use of psychostimulants and 
an increase in the causation of tics (Erenberg, 2005). Another CNS stimulant, 
caffeine, has also been suggested to influence the expression of tics in TS. Caffeine is 
a competitive antagonist at adenosine receptors, and has been shown to enhance the 
effects of dopamine agonists. The dopaminergic system may therefore modulate or 
facilitate the expression of tics, as demonstrated by dopamine mimetic receptor 
blockers (such as haloperidol), which has been shown to have a suppressant action on 
tics (Jankovic, 1982). Furthermore, tics may worsen due to the further stimulation of 
an already overactive dopaminergic system by caffeinated products (Müller‐Vahl et 
al., 2008).  
 
Schaefer, Chow, Louis and Robakis (2017) recently found, when conducting a 
retrospective chart review of outpatients over age 21, that one third of the patients 
with TS identified re-emergence of tics following the intake of alcohol and caffeine. 
The case of two cousins with tic-related symptoms who, over a 3-year period of being 
observed and having tics recorded, were also reported to display caffeine-precipitated 
tics (Davis and Osorio, 1998).  
 
Refined sugars 
Refined sugar is a processed food and is commonly found as a combination of 
glucose and fructose, known as sucrose. It is often used by food manufacturers to 
sweeten food, but has been shown to cause a rapid rise in blood sugar that could 
increase an individual’s risk of mood swings, diabetes, cancer and obesity (Horton 
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and Yates, 1987). Refined sugar may also exacerbate some psychological disorders. 
For example, refined sugar has been found to cause more behavioural problems in 
ADHD (Bateman et al., 2004), and TS respondents have reported a worsening of their 
tics after the consumption of refined white sugar (Müller‐Vahl et al., 2008). 
 
Johnson et al., (2011) proposed that, in the case of individuals with ADHD, the 
increase of dopamine (caused by sugar intake) might lead to a reduction in the 
number of D2 receptors and/or a decrease in extracellular dopamine itself. This could 
potentially lead to desensitization of the dopamine-signalling axis, meaning it is 
possible that children with ADHD may then ingest more sugar in an effort to correct 
the dopamine-deficient state. Therefore, children with TS, a population also identified 
as having dysfunction of the dopamine system, may also show a tendency to consume 
high sugar foods, which may in turn exacerbate tics. 
 
Magnesium deficiency 
Magnesium is a mineral that has a crucial role in how the body regulates and 
functions, and it is also essential to the biochemical systems that contribute to the 
body’s health maintenance. The classic symptoms of mineral deficiency can often be 
linked to their physiological role of controlling healthy levels of calcium and 
potassium in the body (Laires, Monteiro and Bicho, 2004). A deficit in Magnesium 
can result in seizures, anxiety, muscle spasms and tics, migraine headaches, 
depression and chronic fatigue (Galland, 1993). All of these symptoms are frequently 
observed in a range of neuropsychiatric conditions (such as TS). However, the 
potential contribution of magnesium deficiency is currently unclear. 
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Grimaldi (2002) reported that children with TS have a magnesium deficiency, which 
has been attributed to neuromuscular hyperexcitability, as well as a rise in 
convulsions, chorea and athetoid movements. A magnesium deficiency has also been 
suggested as the precipitating event for biochemical effects on substance P, 
kynurenine, NMDA receptors and vitamin B6, which may provoke the symptoms 
evidenced by children with TS, such as facial muscles ending in tongue protrusions. 
Furthermore, a magnesium deficiency has been related to an increased release of 
dopamine, more defensive behaviour and greater modulation of serotonin receptors. It 
can also lead to other symptoms, including migraine, which is found to be more 
frequent among patients with TS (Planells, Lerma, Sanchez-Morito, Aranda and 
Llopis, 1997). 
 
In other psychological disorders (such as ASD), oral supplementation of magnesium 
and vitamin B have been shown to significantly improve the ability to interact in 
social situations, and to increase communication and intellectual abilities (Mousain-
Bosc et al., 2006). Research is needed to investigate the potential of using magnesium 
and vitamin B6 as a method of treatment in TS, for the reduction of symptoms. If 
successful, this could help reduce tics and the need for pharmacological interventions 
(including neuroleptic drugs). Importantly, magnesium and B6 can both be 
administered via food intake and are associated with few side effects (Garcia-Lopez, 
et al., 2009).  
 
Iron deficiency  
Iron is critical for producing haemoglobin, a protein that helps red blood cells deliver 
oxygen throughout the body. An iron deficiency is one of the most commonly 
                                                                                                 Diet and Nutrition in TS 11 
reported nutritional deficiencies found in the general public; it results in a lack of 
oxygen getting to tissues and organs, which can lead to anaemia. Iron deficiency, with 
or without anaemia, can also impair emotions and cognition, and in other 
psychological disorders, has been associated with developmental delay in infants, 
mood changes and lack of concentration in children (Latif, Heinz and Cook, 2002). 
 
Low ferritin and serum iron levels have frequently been found in both children and 
adults with TS. Whilst, in the brain, small caudate nucleus and putamen (forming the 
dorsal striatum) are considered part of the pathophysiology of TS, further examination 
within this group found this to be particularly the case for those with lower ferritin 
iron levels (Gorman et al., 2006). It has been suggested that low levels of iron may 
contribute to hypoplasia of the caudate putamen, increasing the risk for both 
development and severity of tics. In addition, the inability to control tics may be a 
result of smaller cortical volumes, also linked to low levels of iron (Gorman et al., 
2006). Iron metabolism has also been implicated in the pathophysiology of TS, 
through its impact on the metabolism of dopamine and, possibly, other 
neurotransmitters (Cortese et al., 2008).  Therefore, given the biological links 
showing low levels of iron may be symptomatic of children with TS, the relationship 
between iron supplements and symptoms of TS may be warranted. 
 
Gluten intolerance  
Anecdotal reports have suggested that children with TS have abnormal reactions to 
gluten, and the chemical manipulation of this protein has been suggested to result in a 
substance that exacerbates tics. It can also contribute to difficulties in the breakdown 
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of a protein found in dairy products, called casein (Millward, Ferriter, Calver and 
Connell‐Jones, 2008).   
 
Celiac disease, a common digestive condition caused by an abnormal immune 
reaction to gluten, is more likely to occur in association with other psychological 
disorders such as ADHD, Autism, Learning and tic disorders (Pynnönen et al., 2005).  
A recent case reported in the literature involved a 13-year-old female with a 10-year 
history of tics and Obsessive-Compulsive Disorder. Despite a family history for celiac 
disease, she failed to show symptoms of the disease herself, but instead met the 
criteria for Non-Celiac Gluten Sensitivity. After 1-week of being placed on a gluten-
free diet (GFD) her tics were reported to diminish, and within a few months the tics 
appeared to completely disappear (Rodrigo, Huerta and Salas-Puig, 2015). However, 
to date, no empirical studies have directly addressed the use of a gluten diet in 
individuals with TS. 
 
Low levels of Amino acids 
Protein in food is broken down into Amino acids, which are essential acids for every 
aspect of the body. Amino acids give cells their structure, are essential for repairing 
tissue, have an important role in the transport and storage of nutrients, and are 
important for every metabolic process. There is some evidence to suggest that 
children with TS suffer from low levels of amino acids, such as 5-hydroxtryptophan 
(5HTP), which could be alleviated through a healthy diet and/or dietary supplements.   
 
N-acetylcysteine (NAC) is commonly found in food and is an antioxidant derived 
from amino acid, L’cysteine synthesized by the body. In addition to showing few side 
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effects, NAC has been found to be effective in the treatment of a range of clinical 
disorders including OCD, and adult trichotillomania (Grant et al., 2009). More 
recently N-acetylcysteine, has been addressed as a possible treatment in TS, targeting 
repetitive behaviours by reducing frequency and intensity of premonitory urges via 
the modulation of glutamate (Bloch et al., 2016).  
 
2) Dietary interventions in children with TS 
 
Despite the suggestion that certain allergens in food might exacerbate tic-related 
symptoms in children with TS (Brunn, 1984), there is very little research addressing 
nutritional factors (such as food additives, allergies and diets) on tics and other 
symptoms of TS. Furthermore, the limited research available has produced 
contradictory findings with some results identifying no effect of food intake and/or 
special diet on symptom fluctuation (Silva et al., 1995), and other findings showing 
specific foods increase symptoms in as many as 40% of children with TS (Bornstein, 
Stefl and Hammond, 1990). In the case of Silva et al., (1995), the survey used a small 
sample (N=14), did not include a comparison group, and only addressed vitamin and 
mineral supplements. The combination of these factors therefore hinders the 
interpretation of these findings. In comparison, Bornstein et al., (1990) included a 
wider sample of individuals with TS (N=763) ranging in age from 4- to 76-years 
(mean 18.6), but failed to report the use of any medication.   
 
Mantel et al., (2004) directly addressed the use of nutritional supplements in TS by 
administering a survey of Complimentary Alternative Medication (CAM) use to 500 
people on the mailing list of the New York Chapter of the Tourette Syndrome 
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Association, and the subscription list of Latitudes (a newsletter addressing CAM use 
for neurological conditions). The study surveyed 115 individuals with TS and found a 
staggering 101 respondents (87.7%) used supplements to control tics. Amongst the 
most commonly used supplements, were vitamin B (60-70 respondents), followed by 
vitamin C/E, calcium and magnesium (55 respondents). Furthermore, younger 
participants were more likely to report a reduction in motor and vocal tics with the use 
of supplements than older participants. For example, 70% of 11- to 18-year-olds 
reported a reduction in motor tics, and 55% in vocal tics, with the use of supplements, 
whereas only 50% of respondents over 18-years-old felt they had seen a reduction in 
motor tics, and 40% in vocal tics. While no incentives were offered for taking part in 
the study, respondents were recruited from a publication whose readership was aimed 
at CAM treatments for neurological conditions. Therefore, it is important to highlight 
that respondents may have been more likely than other individuals with TS to already 
use a CAM, and consequently be more complimentary about its effects. 
 
Kompoliti, Fan and Leurgans (2009) further investigated the use of CAM, and 
surveyed 100 adult patients and parents/caregivers of children with TS. CAM 
treatments related to nutrition assessed the use of dietary supplements, vitamins, and 
diet alterations. The findings revealed that 64% of the sample had used at least one 
CAM; 21 used vitamin supplements; 15 used dietary supplements; and 9 used diet 
alterations. Dietary supplements used included flaxseed oil (9%) and fish oil (14%). 
However, no details were provided regarding the specific vitamins used, or how 
regularly they were taken. There was also no measure given, which assessed changes 
in tics with the use of dietary supplements. The data gained from the study 
demonstrated many of the respondents were using CAM in addition to their current 
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medication (60%), making the reported benefits of CAM difficult to determine. 
Importantly, the motivations for using CAM were not related to dissatisfaction with 
current and/or conventional treatments, tic severity or side effects of medication  
 
The sample in the Kompoliti et al. study was also problematic as a large proportion 
were well educated and of a high socioeconomic status, with 47% of the sample 
reported financing CAM themselves. The reported benefits of CAM in lower 
socioeconomic status groups are therefore less well understood. Interestingly, 80% of 
those who had reported using a CAM had initiated its use without informing their 
doctor. This may reflect the little support amongst professionals for the idea of a 
relationship between diet and tic related symptoms in TS (Kompoliti et al., 2009). In 
support of this, a survey investigating knowledge of symptoms and treatment, 
administered to 67 physicians and psychologists, found that amongst those who had 
treated at least one person with TS, only 13% believed special diets to affect tics 
(Marcks, Woods, Teng and Twohig, 2004).  
 
In a further survey, carried out by Müller‐Vahl, Buddensiek, Geomelas and Emrich 
(2008), only 34% of 224 respondents with TS (from a pool of 887 people from 
German Tourette syndrome self-aid group), had ever adopted the use of a special diet 
to improve symptoms. While the demographics measured included age and gender, no 
information on comorbid disorders was sought. Sixty per cent of responses were from 
people with TS, and the remaining 40% were from carers/parents (96% of 
respondents confirmed the diagnosis was provided by a medical professional). 
Respondents were asked to rate the influence of 32 different foods and drink items on 
their tics using a six-point scale (0= no influence, 1= mild improvement, 2= marked 
                                                                                                 Diet and Nutrition in TS 16 
improvement, 3= mild deterioration, 4= marked deterioration 5= I do not eat). 
Examples of the different food types specified include: meat (pork, beef and poultry), 
dairy products, yeast, wheat, fruits, preserving agents, refined white sugar, coffee, 
coke and alcoholic drinks. Respondents were also requested to state the use of 
previous special diets (such as sugar and gluten free), and to rate whether they 
believed the diet had had an influence on the presentation of tics, using the 
aforementioned scale. Müller‐Vahl et al.,’s (2008) findings highlighted the influence 
of some special diets on tics. For example, oligoantigenic (elimination diet that seeks 
to resolve inflammation in the gut) and sugar-free diets were reported to significantly 
reduce tics. Moreover, a significant increase in tics was related to the consumption of: 
coke, black tea, coffee, persevering agents, refined sugar and sweeteners. In fact, 34% 
of respondents reported tics to worsen with the consumption of coffee, and 47% with 
the consumption of coke. Following from these results, experimental studies are now 
needed to address changes in the fluctuation of tics following the intake of some of 
these identified food types. By closely monitoring any improvements and/or 
deterioration would enable a clearer understanding of their effects on tics, both short 
and long term. 
 
There appears to have been only two experimental placebo controlled trials 
addressing nutrition in TS. In the first of these, Gabbay et al., (2012) investigated the 
effects of Omega-3 fatty acids (O3FA) on the symptoms of children and adolescents 
with TS. Essential fatty acids and phospholipids are both required for normal neuronal 
structure and function and must be supplied through the diet. Gabbay et al., (2012) 
used a randomised, double blind, placebo-controlled trial of 33 children and 
adolescents (aged 6- to 18-years) with TS. Children were randomly assigned to O3FA 
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or placebo (olive oil) for 20 weeks, from a pharmacist. While O3FA were not found 
to significantly reduce tic scores, and showed little effect on obsessive-compulsive, 
anxiety and depressive symptoms, they were suggested as being beneficial to some 
tic-related symptoms. For example, children receiving O3FA reported significantly 
lower scores on the Yale Global Tic Severity scale than those receiving olive oil. The 
findings suggest that a diet with high levels of O3FA may help alleviate some tic-
related symptoms. The authors noted that the detection of more subtle treatment 
effects might have been enhanced by a larger sample, and with use of an alternative 
placebo (olive oil might have had a therapeutic effect due to its antioxidative 
properties). Further experimental research addressing the effects of 03FA in TS, could 
also inform the recommended doses required to establish improvements in any 
symptoms.  
 
The second study addressed the use of amino acids in TS.  Bloch et al., (2016) 
assessed the efficacy of the amino acid N-acetylcysteine (NAC) in paediatric TS using 
a double-blind, placebo-controlled, add-on study. Thirty-one children and adolescents 
aged 8- to 17-years-old were randomly assigned to either the NAS condition (N=17) 
or the placebo condition (N=14). Participants in the placebo trial were offered NAC 
treatment after completion of the study. Over a 12-week period, the trial failed to 
demonstrate a benefit of NAC on the severity of tics, as measured by the Yale Global 
Tic-Scale. The lack of effectiveness of NAC found in TS compared to studies 
addressing OCD may be due to differences in the clinical presentations of the two 
disorders (e.g. gender, pathology) and/or the fact that when effectiveness has been 
reported, this has involved the use of older populations with OCD. The 
aftermentioned study benefits from not only the adoption of a randomised placebo 
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design, but also considers secondary symptoms of the disorders including OCD, 
depression, anxiety and ADHD.  However, the authors note important baseline 
differences between the placebo and NAC groups, such that they differed 
significantly in the severity of these comorbid symptoms, and use of antipsychotic 
medication.  Both of which could have influenced the effectiveness of NAC.  
 
 
DISCUSSION 
 
This scoping review aimed to summarise the research that has investigated the effects 
of certain types of foods on tics, and to map out the existing studies that have 
explored potential dietary interventions for the alleviation of tics. From the very 
limited literature available, no one diet has been shown to benefit individuals with TS, 
although certain diets (such as oligoantigenic and sugar-free diets) were reported to 
alleviate tics (Müller‐Vahl et al., 2008). In addition, children with TS may be more 
prone to unbalanced, and often energy dense diets, which can predispose children to 
weight gain and its associated health complications. Therefore more studies 
addressing dietary habits in this group of children are clearly warranted (Liang et al., 
2015).  
 
The literature discussed in this review has highlighted the shortcomings of the few 
studies that have begun to address this topic. Common limitations include small 
samples, the use of case studies, no measure for changes in tic frequency, failure to 
include appropriate comparison groups and, in some cases no consideration of any 
comorbid disorders (e.g. Davis, 1998). The different methodologies incorporated by 
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the studies, such as the fact that some report the use of diagnostic criteria, and others 
simply specify that participants had some sort of tic disorder, further hampers the 
ability to draw comparisons across studies. Furthermore, many of the studies are 
based purely on observations or self-report surveys completed by the individual with 
TS or a parent/caregiver (Mantel et al., 2005).  
 
The importance of more experimental studies, with the inclusion of placebo 
conditions, is needed to address the influence of diet and nutrition on tics. However, 
only by research first establishing a clearer relationship between diet and the 
symptoms of TS, using larger samples of children, may randomised clinical trials be 
warranted. Further findings would help inform better healthcare guidelines, and could 
also offer an alternative intervention to pharmaceutical treatments in the management 
of tics. 
 
The current review outlines the clear need to understand dietary behaviours in TS 
further. Anecdotal evidence has shown that individuals with TS, and parents and 
caregivers of children with TS, are investing in the use of dietary and nutritional 
supplements, despite the lack of evidence detailing any benefits, side effects and 
recommended doses. Despite the lack of a clear evidence base to support the idea that 
changes in diet could alleviate some of the symptoms of TS, the manipulation of diet 
for future studies to further our understanding of this relationship appears to come as 
little cost, compared to some of the adverse side effects of other treatments currently 
being offered to TS. Understanding dietary and nutritional factors in TS may be 
useful in informing our understanding of some of the associated causes of tic 
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behaviour, and may even provide alternative interventions for improving the quality 
of life in these families.  
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Table 1:  Main types of treatment for TS. 
Treatments  Types of Treatments How they work Adverse effects 
Self-help The individual with TS can 
use a range of strategies to 
help alleviate tics. 
 
•Avoiding stress, anxiety 
boredom and becoming too 
tired 
 
  
Time consuming, few long 
term beneficial effects, more 
successful for less severe 
cases and in older children 
and adults. 
Psychoeducation  Educating both the 
individual with TS and other 
people about the condition. 
Learning about Tic Disorders 
and TS.  Can include 
learning about the causes, the 
usual course of tics, and the 
types of co-occurring 
conditions that often occur in 
individuals with TS. 
Time consuming, and not 
always clear how best to 
teach others about the 
syndrome. May help an 
individual with TS, to 
understand their condition 
more, but does not 
necessarily lead to an 
improvement in their 
symptoms. 
Medication First  Generation 
Neuroleptics 
 
Medications that inhibit 
dopamine reuptake  
 
High rate of extrapyramidal 
side effects, including 
Tardive dyskinesia, rigidity, 
bradykinesia, dystonias,, 
tremor, and akathisia.  
Second Generation 
Neuroleptics 
 
Lower risk of movement side 
effects. Associated with 
significant lipid and prolactin 
elevation, weight gain, and 
type II diabetes. 
Behaviour Therapies  Habit Reversal Therapy 
(HRT) 
•Tic-awareness training- to 
educate others about the 
condition  
• Help the person to identify 
when tics occur and the types 
of urges felt before the tics. 
•Helps to identify new 
responses to do when a 
person feels the urge to tic  
Found to be less beneficial in 
individuals whose symptoms 
persist have a more chronic 
form of the disorder. 
Requires practice outside of 
the therapy sessions. Lack of 
therapists trained in HRT. 
Exposure and response 
prevention (ERP) 
Teaches the person to 
suppress the growing feeling 
you need to tic until it 
subsides. Can be used to 
improve all the individuals 
tics at the same time. 
Requires practice outside of 
the therapy sessions. Some 
individuals have reported 30-
40% reduction in tics. 
Can be very demanding on 
young children. 
 Relaxation Training  Teaches the individual with 
TS, to cope with stress. 
Not found to be very 
effective for more severe 
cases. 
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Involves deep breathing and 
tensing and relaxing muscles 
in the body. 
Cognitive Behavioural 
Therapy 
Usually offered in 8-12 
weekly or fortnightly 
sessions with a therapist. 
Changes are made through 
cognitive restructuring, and 
through behavioral and 
physiological modifications 
Dependent often upon an 
NHS referral. 
Surgery Deep brain stimulation It has been used in only few 
severe cases 
Under anaesthetic, a small 
number of electrodes are 
placed in areas of bran 
associated with the tics. 
Thin wires run from the 
electrodes to a pulse 
generator, placed under the 
skin of your chest. This gives 
out an electric current to help 
regulate the signals in your 
brain and control your tics. 
Uncertainties exist 
surrounding how effective 
and safe it is. 
 
Only been used in severe 
cases and in adults. 
 
 
 
Table 2: Summary of research addressing diet and dietary interventions in TS 
Author(s), 
year 
Participants 
diagnosis, 
gender and age 
Comorbid 
symptoms 
Purpose Method Results 
Observation and Case reports 
Bruun, 1984 TS (n=300) Not 
stated 
Not stated  A review of 12 
years of cases 
of TS  
Clinical 
observations 
Seasonal allergic 
responses or the 
ingestion of 
allergens in food 
Davis, 1998 Normal 
Development with 
tics (n=2) no TS 
diagnosis of 
phonic or vocal 
tics reported.  
 
11 and 13 year old 
male cousins 
 
Other than tics 
normal 
development  
Not stated To observe 
whether intake 
of caffeine 
would 
influence tics 
3 year 
observational 
design 
Tics exacerbated 
with 
consumption, and 
decreased with 
discontinuation, 
of caffeine-related 
products. 
Rodrigo, 
Huerta, Salas-
Puig (2015) 
TS (N=1) 13yrs 
female  
OCD, celiac 
disease* 
To assess any 
clinical 
improvements 
in symptoms 
after the use of 
a gluten-free 
diet 
Observation Diminishment of 
tics 1 week after 
beginning diet. 
After 2.5 years is 
in complete 
remission from 
tics with only the 
occasional flare 
up 
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Parent and Self-report 
Silva, Munoz, 
Barickman & 
Friedhoff, 1995 
TS (n=14) 
10 males, 4 
females 
6.6-14.5 years  
(mean, 10.3 ± 2.5) 
 
8 participants 
assessed for tics 
using the Yale 
Global Tic severity 
scale by trained 
clinical rater. 
 
None of 
participants had 
ever received 
medication. 
Not stated  To assess how 
29 different 
environmental 
factors affected 
TS. 
Self–report 
questionnaire 
10 factors 
reported as having 
no impact on tics 
(alcohol, coffee, 
vitamins, foods, 
and special diets, 
cigarette smoking, 
exposure to hot 
cold weather and 
living away from 
home). 
 
17 factors 
increased tics 
(e.g. anxiety, 
emotional trauma 
and fatigue, 
watching TV and 
social gatherings). 
Mantel et al., 
2004 
TS (n=115) 
 
Both under and 
over 18 years (33 
<10y; 51 11-18y; 
19 >18y; and 12 
unspecified). 
Means and sd not 
presented. 
ADHD (78)* 
OCD (46)* 
Autism (4)* 
A breakdown of 
those with 
kidney disease, 
heart disease, 
allergies, asthma 
and aggression 
also reported. 
To explore the 
use of 
supplements 
and CAM 
among TS 
patients  
Parent and 
self-report 
survey  
87.7% used 1 or 
more of 29 
supplements to 
control 
symptoms. 
 
33% reported 
improved benefit 
with the use of 
dietary 
modification  
Muller-Vahl, 
Buddensiek 
2008 
TS  (n=224) 
5–72 years  
M=24.7 years  
SD: ±14.5 
Not stated  To assess 
influence of 
food and drinks 
in TS  
Parent and 
self-report 
survey 
Tics increase 
following 
consumption of 
coke, coffee, 
black tea, 
preserving agents, 
refined white 
sugar and 
sweeteners. 
 
The use of algio-
antigen and sugar 
free diet was 
found to 
significantly 
reduce tics. 
Kompoliti, 
Wenquin & 
Leurgans, 2009, 
TS (n=100)  
 
76 males and 23 
females (aged: 
21.5 ± 13.5y) 
 
39% patient, 27% 
parent/guardian 
and 24% both 
cases. 
  
TS diagnosis 
confirmed. 
 
CAMS TS users 
and TS non-users 
did not differ on 
gender, age, 
general health, tic 
severity, 
medication, 
income or 
educational level. 
Made by a 
neurologist 
 
Comorbidity 
included ADHD 
(DSM-IV 
criteria), OCD 
(Leyton 
Inventory). 
 
Affective 
disorders 
(Depression: 
Hamilton 
Inventory; 
Anxiety DSM-
IV criteria). 
To monitor the 
use of 
Complementary 
and Alternative 
Medicine Use 
(CAMS) 
Parent and 
self-report 
survey on 
CAMS 
64% has used at 
least one CAMS 
 
56% reported 
improvement with 
CAMS 
 
15% used diet 
supplements 
 
9% diet 
alterations 
 
 
Experimental Placebo Designs 
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Gabbay et al., 
2012 
Thirty-three 
children and 
adolescents (aged 
6–18yrs) with TS 
OCD* To examine the 
efficacy of  
O3FA in tic 
severity 
compared with 
a placebo (olive 
oil)  
A placebo-
controlled 
trial over 20 
weeks 
Some benefits of 
O3FA in 
ameliorating tic-
related 
impairment, but 
not tics per se. 
Bloch et al., 
2006 
Thirty-One 
children and 
adolescents (aged 
8-17 yrs) with TS 
Clinical 
evaluation 
involved 
psychiatric 
history, mental 
state, clinical 
assessment of 
past medication 
and behavioural 
treatment. 
 
DSM-IV criteria 
for diagnosis.  
 
Severity of Tics 
(Yale Global 
Tic Severity 
Scale YGTSS) 
and Premonitory 
Urges for TICS  
 
OCD (CY-
BOCS)(N=6) 
 
ADHD (ADHD-
RS)(N=15) 
 
Anxiety and 
Depression  
(MASC) 
 
Pharmacological 
treatment for 
tics (current and 
past use)( 
N=22) 
 
Current 
Pharmacological 
treatment for 
tics (N=13) 
To examine the 
efficacy of N-
Acetylcysteine 
(NAC) in 
treatment of 
tics in 
paediatric TS. 
A double-
blind, placbo 
control study 
over a 12 
week period. 
Children 
were either 
assigned  
NAC  or 
placebo. 
Two-dropouts, 
one from each 
group. 
 
No significant 
differences 
between the two 
groups in the 
reduction of 
severity of 
premonitory urges 
associated with 
tics (PUTS), or in 
improving the 
severity of tics 
(YGTSS) 
 
No significant 
differences in 
reducing severity 
of comorbid 
symptoms, 
including OCD, 
ADHD and 
Anxiety. 
 
Depression 
symptoms 
increased in 
placebo. 
*Simply based on parent and/or self report 
 
